Skip to main content
SpringerLink
Log in

Velaglucerase-α

Coldness in infused arm: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zimran A, et al. Reduction in intravenous infusion duration of enzyme replacement therapy to ten minutes with velaglucerase alfa in adult patients with type 1 gaucher disease. Blood 130 (Suppl. 1): no pagination, Dec 2017 [abstract] -Israel

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Velaglucerase-α. Reactions Weekly 1695, 354 (2018). https://doi.org/10.1007/s40278-018-44181-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44181-7

Search

Navigation